Actively Recruiting
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Led by Memorial Sloan Kettering Cancer Center · Updated on 2025-10-09
480
Participants Needed
7
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The overarching long-term goal of the Integrative Medicine for Patient-reported Outcomes Values and Experience (IMPROVE) research program is to evaluate whether integrating a virtual mind-body programming, Integrative Medicine at Home (IM@Home), will improve patient perceived values, outcomes, and experiences as they undergo systemic cancer treatment such as chemotherapy, immunotherapy, radiotherapy, targeted agents, cytoreductive surgery.
CONDITIONS
Official Title
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years or older
- Karnofsky score 60 or greater
- Life expectancy greater than six months
- English speaking
- Diagnosis of head and neck tumors, thoracic tumors, gynecological tumors, melanoma, breast cancer, or gynecologic cancer
- Actively receiving systemic oncological treatment or radiotherapy, or within 4 weeks of radiotherapy completion or primary cytoreductive surgery
- Worst fatigue over the last 7 days rated 4 or greater on (0-10 scale)
- Patients with diagnosis or suspicion of gynecologic malignancy who have completed definitive first line treatment (maintenance hormonal or targeted therapies allowed)
- Patients with advanced cancers including Stage III or IV lung, pancreatic, cholangiocarcinoma, liver, ampullary, gastrointestinal, ovarian, fallopian tube, gynecologic, breast, testicular, genitourinary, sarcoma, melanoma, endocrine cancers, lymphoma, myeloma, or leukemia
- Actively receiving oncological treatment, radiotherapy or active surveillance
- Completed active cancer treatment (e.g., surgery, radiation, chemotherapy) with fatigue rated 4 or greater on (0-10 scale)
You will not qualify if you...
- Cognitive impairment preventing response to study assessments or requiring use of Legally Authorized Representatives
- Unwillingness to accept random assignment
- Concurrent enrollment in other ongoing integrative medicine trials with symptom/toxicity as primary outcome (other therapeutic protocols allowed)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, United States, 07920
Actively Recruiting
2
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, New Jersey, United States, 07748
Actively Recruiting
3
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, United States, 07645
Actively Recruiting
4
Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities)
Commack, New York, United States, 11725
Actively Recruiting
5
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, United States, 10604
Actively Recruiting
6
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
7
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, New York, United States, 11553
Actively Recruiting
Research Team
K
Karolina Bryl, PhD
CONTACT
M
Michael Postow, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here